ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Business

Sumitomo Chemical to take stake in nucleic acid startup

Japanese companies joining race to develop next-generation biomedicines

Sumitomo Chemical produces pharmaceutical intermediaries at a plant in Osaka.

TOKYO -- Japan's Sumitomo Chemical will make inroads into the emerging field of nucleic acid-based medicines, investing 4 billion yen ($35.7 million) in a domestic upstart.

The chemical maker is to acquire a nearly 20% interest in the company, Fukuoka Prefecture-based Bonac, through a new-share placement as soon as this month.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more